Cervical Cancer Series (2021)
Prevention of cervical cancer with population-based screening has been a story of success. But it is also a story that is evolving and increasingly confusing as more data and new technologies emerge. This four-part series offers clinicians and others in health care a practical, comprehensive educational experience, from basic to advanced information about screening, diagnosis, treatment, new technologies, disparities, and prevention of cervical cancers and its precursors. Using case studies and practice with the app for the newly revised ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors that were released in April 2020 attendees will be prepared to put this knowledge into immediate practice.
This recorded webinar series by frontline experts consists of 4 sections which can be completed in any order and at your own pace.
- Physicians
- Physician Assistants
- Nurse Practitioners
- Nurses/Certified Nurse Midwives
- LVNs
Section 1: Exploiting the Natural History of HPV to Prevent Cancer and the Strategy of Screening for Precursor Lesions
After this section, you will be able to:
- Discuss two differences between low-risk and high-risk HPV
- Describe HPV-based screening: HPV-alone and co testing with cervical cytology
- List 3 HPV related cancers
Section 2: The 2019 ASCCP Risk-based Management Guidelines: Updated Management for Abnormal Screening Tests
After this section, you will be able to:
- Describe the risk-based paradigm for managing abnormal cervical cancer screening test results
- Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up
- Demonstrate use of the ASCCP app to apply the new guidelines
Section 3: Patient-centered Conversations About HPV and Abnormal Test Results
After this section, you will be able to:
- Discuss relevant facts about HPV with patients
- Demonstrate use of plain language
- Summarize the finding of studies of the efficacy, safety and risks of HPV immunization
Section 4: Cervical Cancer Pathology + Challenging Case Studies in the Implementation of the Risk Based Management Guidelines
After this section, you will be able to:
- List management options for patients with HSIL and positive HPV, negative 16
- Describe the follow up for people with a history of high-grade disease who are over age 65
- Demonstrate correct use of the application for the 2019 ASCCP Risk Based Management Guidelines
The course fee includes CEU processing (CPH = 7.0; CHES = 7.0; Nursing = 8.4; CME = 7.0).
Certified in Public Health (CPH):
This event was sponsored by Essential Access Health, an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners for 7.0 credits.
Health Educators (CHES®):
Essential Access Health, provider #98021, is designated as a provider of Category 1 continuing education contact hours in health education by the National Commission for Health Education Credentialing, Inc. Health educators attending this program may report up to 7.0 contact hours.
Nursing:
Provider approved by California Board of Registered Nursing. Provider #CEP 12241, for 8.4 contact hours.
CME:
Essential Access Health is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
Essential Access Health designates this Live Activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.